PharmaCielo (PCLO.V) reported first quarter net loss of C$1.4 million compared with C$1.3 million, a year earlier.
Revenue increased to C$1.4 million in the three months ended June 30, 2026, compared with C$323,000, a year-ago. The increase in revenue was driven primarily by broader geographic footprint and new flower sales to Europe, it said.
The company's shares last traded Aug. 26, closing at C$0.06 on the TSX Venture Exchange.